Azopt and Overdose - a phase IV clinical study of FDA data

Summary:

Overdose is reported as a side effect among people who take Azopt (brinzolamide), especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years also take Xalatan, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Overdose when taking Azopt. It is created by eHealthMe based on reports of 7,917 people who have side effects when taking Azopt from the FDA, and is updated regularly.

What is Azopt?

Azopt has active ingredients of brinzolamide. It is often used in glaucoma. eHealthMe is studying from 8,058 Azopt users. Check the latest studies of Azopt.

What is Overdose?

Overdose is found to be associated with 2,218 drugs and 2,472 conditions by eHealthMe. Check the latest studies of Overdose.

On Jul, 14, 2026

7,917 people reported to have side effects when taking Azopt.
Among them, 22 people (0.28%) have Overdose.

Among these 22 people:

How long have people been on Azopt when they have Overdose? *

What is the gender of people who have Overdose when taking Azopt? *

female: 68.18 %
male: 31.82 %

What is the age of people who have Overdose when taking Azopt? *

What are other drugs people take besides Azopt? *

What are other side effects people have besides Overdose? *

Intraocular Pressure Increased: 5 people, 22.73%
Cataract (clouding of the lens inside the eye): 3 people, 13.64%
Diarrhea: 3 people, 13.64%
Insomnia (sleeplessness): 3 people, 13.64%
Macular Oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken): 2 people, 9.09%
Visual Impairment: 2 people, 9.09%
Muscle Spasms (muscle contraction): 2 people, 9.09%
Color Blindness (inability to view some colour): 2 people, 9.09%
International Normalised Ratio Increased: 2 people, 9.09%
Cheyne-Stokes Respiration (abnormal pattern of breathing combination of slow and faster): 1 person, 4.55%

What are the existing conditions these people have? *

Pain: 4 people, 18.18%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 18.18%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 13.64%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 9.09%
Diarrhea: 2 people, 9.09%
Diabetes: 2 people, 9.09%
Constipation: 2 people, 9.09%
Osteoporosis (bones weak and more likely to break): 2 people, 9.09%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 9.09%
Conjunctivitis Allergic (inflammation of the conjunctiva due to allergy): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Azopt and have Overdose?

- Check whether Overdose is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Azopt:

Azopt (8,058 reports)

Overdose treatments and more:

Overdose (229,245 reports)

Browse all side effects of Azopt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Overdose:

Overdose (2,218 drugs)

Browse all the conditions that are associated with Overdose:

Overdose (2,472 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on brinzolamide (the active ingredients of Azopt) and Azopt (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.